Mark Guinan
Director/Board Member at UPHEALTH, INC.
Net worth: 167 030 $ as of 2024-03-30
Profile
Presently, Mark J. Guinan holds the position of Chief Financial Officer & Executive Vice President at Quest Diagnostics, Inc. Mr. Guinan is also on the board of Myovant Sciences Ltd., Q Squared Solutions Holdings Ltd. and Roivant Sciences, Inc. He previously occupied the position of Chief Financial Officer & Senior Vice President at Hill-Rom Holdings, Inc., Vice President-Finance of Global Pharmaceutical Group, Chief Procurement Officer at Johnson & Johnson and Principal at Procter & Gamble Co. Mark J. Guinan received an undergraduate degree from the University of Notre Dame and an MBA from Olin Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
UPHEALTH INC
0.86% | 2024-01-30 | 160,606 ( 0.86% ) | 167 030 $ | 2024-03-30 |
Mark Guinan active positions
Companies | Position | Start |
---|---|---|
UPHEALTH, INC. | Director/Board Member | 2022-12-04 |
Q Squared Solutions Holdings Ltd.
Q Squared Solutions Holdings Ltd. Medical/Nursing ServicesHealth Services Part of IQVIA Holdings, Inc., Q Squared Solutions Holdings Ltd. is a British company that provides health services. The private company is based in Reading, UK. | Director/Board Member | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Director/Board Member | - |
Former positions of Mark Guinan
Companies | Position | End |
---|---|---|
MYOVANT SCIENCES LTD. | Director/Board Member | 2023-03-09 |
QUEST DIAGNOSTICS INCORPORATED | Director of Finance/CFO | 2022-07-10 |
HILL-ROM HOLDINGS, INC. | Director of Finance/CFO | 2013-07-18 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 2009-12-31 |
PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Training of Mark Guinan
University of Notre Dame | Undergraduate Degree |
Olin Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
JOHNSON & JOHNSON | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
QUEST DIAGNOSTICS INCORPORATED | Health Services |
UPHEALTH, INC. | Health Services |
Private companies | 5 |
---|---|
Hill-Rom Holdings, Inc.
Hill-Rom Holdings, Inc. Hospital/Nursing ManagementHealth Services Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL. | Health Services |
Global Pharmaceutical Group | |
Myovant Sciences Ltd.
Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Q Squared Solutions Holdings Ltd.
Q Squared Solutions Holdings Ltd. Medical/Nursing ServicesHealth Services Part of IQVIA Holdings, Inc., Q Squared Solutions Holdings Ltd. is a British company that provides health services. The private company is based in Reading, UK. | Health Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Mark Guinan